First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization.

Source:http://linkedlifedata.com/resource/pubmed/id/2106740

Download in:

View as

General Info

PMID
2106740